AP2006003616A0 - 4-amino-quinoline quinolizidinyl and quinolizidinylalkyl derivatives with antimalarial activity - Google Patents

4-amino-quinoline quinolizidinyl and quinolizidinylalkyl derivatives with antimalarial activity

Info

Publication number
AP2006003616A0
AP2006003616A0 AP2006003616A AP2006003616A AP2006003616A0 AP 2006003616 A0 AP2006003616 A0 AP 2006003616A0 AP 2006003616 A AP2006003616 A AP 2006003616A AP 2006003616 A AP2006003616 A AP 2006003616A AP 2006003616 A0 AP2006003616 A0 AP 2006003616A0
Authority
AP
ARIPO
Prior art keywords
quinolizidinylalkyl
quinolizidinyl
quinoline
derivatives
amino
Prior art date
Application number
AP2006003616A
Other languages
English (en)
Inventor
Anna Sparatore
Silvia Parapini
Boido Caterina Canu
Original Assignee
Need Pharmaceuticals S R L
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Need Pharmaceuticals S R L filed Critical Need Pharmaceuticals S R L
Publication of AP2006003616A0 publication Critical patent/AP2006003616A0/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • A61P33/02Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A61P33/06Antimalarials
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F15/00Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table
    • C07F15/0006Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table compounds of the platinum group
    • C07F15/0046Ruthenium compounds
    • C07F15/0053Ruthenium compounds without a metal-carbon linkage
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F15/00Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table
    • C07F15/0006Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table compounds of the platinum group
    • C07F15/0073Rhodium compounds
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/553Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having one nitrogen atom as the only ring hetero atom
    • C07F9/576Six-membered rings
    • C07F9/60Quinoline or hydrogenated quinoline ring systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6558Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system
    • C07F9/65583Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system each of the hetero rings containing nitrogen as ring hetero atom
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Biochemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AP2006003616A 2003-10-21 2004-10-18 4-amino-quinoline quinolizidinyl and quinolizidinylalkyl derivatives with antimalarial activity AP2006003616A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT002044A ITMI20032044A1 (it) 2003-10-21 2003-10-21 Chinolizidinil e chinolizidinilalchil-derivati della 4-ammino-chinolina ad attivita' antimalarica
PCT/IB2004/003393 WO2005037833A1 (en) 2003-10-21 2004-10-18 4-amino-quinoline ouinolizidinyl-and quinolizidinylalkyl-derivatives with antimalarial activity

Publications (1)

Publication Number Publication Date
AP2006003616A0 true AP2006003616A0 (en) 2006-06-30

Family

ID=34452253

Family Applications (1)

Application Number Title Priority Date Filing Date
AP2006003616A AP2006003616A0 (en) 2003-10-21 2004-10-18 4-amino-quinoline quinolizidinyl and quinolizidinylalkyl derivatives with antimalarial activity

Country Status (8)

Country Link
EP (1) EP1675855B1 (de)
CN (1) CN1902199A (de)
AP (1) AP2006003616A0 (de)
AT (1) ATE417044T1 (de)
DE (1) DE602004018355D1 (de)
ES (1) ES2319201T3 (de)
IT (1) ITMI20032044A1 (de)
WO (1) WO2005037833A1 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1846401B1 (de) * 2005-02-04 2008-06-18 CTG Pharma S.r.l. Neue 4-aminochinolinderivate als antimalariamittel
ITMI20052008A1 (it) * 2005-10-21 2007-04-22 Ctg Pharma S R L Nuovi antimalarici derivati della 4-aminochinolina

Also Published As

Publication number Publication date
WO2005037833A1 (en) 2005-04-28
CN1902199A (zh) 2007-01-24
ATE417044T1 (de) 2008-12-15
ES2319201T3 (es) 2009-05-05
ITMI20032044A1 (it) 2005-04-22
EP1675855A1 (de) 2006-07-05
EP1675855B1 (de) 2008-12-10
DE602004018355D1 (de) 2009-01-22

Similar Documents

Publication Publication Date Title
SI1583763T1 (sl) Benzoazolilpiperazinski derivati, ki imajo VR1 antagonistično delovanje
IL169112A0 (en) Phosphonooxy quinazoline derivatives and their pharmaceuitical use
GB0401363D0 (en) Hinge unit and hinge structure using the same
IL179640A0 (en) Metastin derivatives and use thereof
IL183216A0 (en) Nepetalactams and n-substituted derivatives thereof
PL1771421T3 (pl) Pochodne N-hydroksyamidowe i ich zastosowanie
IL174512A0 (en) Pyrazolo and imidazo-pyrimidine derivatives
EP1652855A4 (de) Polypeptide mit hirnablagernder wirkung und deren verwendung
IL183217A0 (en) Dihydronepetalactams and n-substituted derivatives thereof
AP2006003820A0 (en) Piperazin derivatives and their use in controllingpests
IL163868A0 (en) Hermiasterlin derivatives and uses thereof
DE60331850D1 (de) Artikel mit antibakterieller und fungizider aktivität
GB0428391D0 (en) Connection and connection part
IL184008A0 (en) 4-cycloalkyl-substituted tetrahydrochinoline derivatives and use thereof as medicaments
IL175020A0 (en) Chemokine variants and their use
IL176358A0 (en) 3-cyano-quinoline derivatives with antiproliferative activity
PL377236A1 (pl) Indazoloamidy wykazujące działanie przeciwbólowe
GB0316910D0 (en) Fluorocombretastatin and derivatives thereof
AP2006003616A0 (en) 4-amino-quinoline quinolizidinyl and quinolizidinylalkyl derivatives with antimalarial activity
GB0318546D0 (en) Quinoxalinones and their use
GB0300804D0 (en) Compounds and their use
GB0411257D0 (en) Cassette and its use
EP1810976A4 (de) Benzonaphthacenglykosidderivat und dessen verwendung
GB0307231D0 (en) 7-Nitroindoline derivatives and their uses
EP1499338A4 (de) 7-hydroxy-16alpha-fluor-5-androsten-17-one und 7-hydroxy-16alpha-fluor-5-androstan-17-one und ihre derivate